Go Pro
→ Trump’s New Currency Reset (From Porter & Company) (Ad)tc pixel Free SIGA Stock Alerts

Siga Technologies (SIGA) Competitors

Siga Technologies logo
$3.00 +0.12 (+4.17%)
Closing price 04:00 PM Eastern
Extended Trading
$2.98 -0.02 (-0.67%)
As of 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

SIGA vs. ESPR, GLAS, GYRE, OCS, and ACHV

Should you buy Siga Technologies stock or one of its competitors? Siga Technologies's main competitors and comparable companies include Esperion Therapeutics (ESPR), Glass House Brands (GLAS), Gyre Therapeutics (GYRE), Oculis (OCS), and Achieve Life Sciences (ACHV). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Siga Technologies compare to Esperion Therapeutics?

Siga Technologies (NASDAQ:SIGA) and Esperion Therapeutics (NASDAQ:ESPR) are both small-cap healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their risk, analyst recommendations, media sentiment, earnings, valuation, institutional ownership, dividends and profitability.

55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 47.4% of Esperion Therapeutics shares are held by institutional investors. 2.7% of Siga Technologies shares are held by company insiders. Comparatively, 1.6% of Esperion Therapeutics shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Siga Technologies has higher earnings, but lower revenue than Esperion Therapeutics. Siga Technologies is trading at a lower price-to-earnings ratio than Esperion Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siga Technologies$94.57M2.28$23.28M-$0.05N/A
Esperion Therapeutics$403.14M2.03-$22.68M-$0.06N/A

Esperion Therapeutics has a consensus target price of $5.54, suggesting a potential upside of 74.21%. Given Esperion Therapeutics' stronger consensus rating and higher possible upside, analysts clearly believe Esperion Therapeutics is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Esperion Therapeutics
1 Sell rating(s)
6 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

In the previous week, Siga Technologies had 1 more articles in the media than Esperion Therapeutics. MarketBeat recorded 1 mentions for Siga Technologies and 0 mentions for Esperion Therapeutics. Siga Technologies' average media sentiment score of 0.63 beat Esperion Therapeutics' score of 0.00 indicating that Siga Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Siga Technologies Positive
Esperion Therapeutics Neutral

Esperion Therapeutics has a net margin of 0.12% compared to Siga Technologies' net margin of -5.19%. Esperion Therapeutics' return on equity of -0.14% beat Siga Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Siga Technologies-5.19% -1.55% -1.32%
Esperion Therapeutics 0.12%-0.14%0.12%

Siga Technologies has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market. Comparatively, Esperion Therapeutics has a beta of 1.07, meaning that its stock price is 7% more volatile than the broader market.

Summary

Esperion Therapeutics beats Siga Technologies on 9 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Glass House Brands?

Siga Technologies (NASDAQ:SIGA) and Glass House Brands (NYSE:GLAS) are both small-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, media sentiment, valuation, risk and dividends.

In the previous week, Glass House Brands had 6 more articles in the media than Siga Technologies. MarketBeat recorded 7 mentions for Glass House Brands and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.63 beat Glass House Brands' score of 0.02 indicating that Siga Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Siga Technologies Positive
Glass House Brands Neutral

Glass House Brands has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Glass House Brands' return on equity of 0.00% beat Siga Technologies' return on equity.

Company Net Margins Return on Equity Return on Assets
Siga Technologies-5.19% -1.55% -1.32%
Glass House Brands N/A N/A N/A

55.4% of Siga Technologies shares are owned by institutional investors. 2.7% of Siga Technologies shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Glass House Brands has a consensus price target of $16.00, suggesting a potential upside of 69.58%. Given Glass House Brands' stronger consensus rating and higher probable upside, analysts clearly believe Glass House Brands is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Glass House Brands
1 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.67

Siga Technologies has higher revenue and earnings than Glass House Brands.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siga Technologies$94.57M2.28$23.28M-$0.05N/A
Glass House BrandsN/AN/AN/AN/AN/A

Summary

Glass House Brands beats Siga Technologies on 8 of the 12 factors compared between the two stocks.

How does Siga Technologies compare to Gyre Therapeutics?

Siga Technologies (NASDAQ:SIGA) and Gyre Therapeutics (NASDAQ:GYRE) are both small-cap healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their media sentiment, dividends, institutional ownership, earnings, valuation, profitability, analyst recommendations and risk.

Siga Technologies has higher earnings, but lower revenue than Gyre Therapeutics. Siga Technologies is trading at a lower price-to-earnings ratio than Gyre Therapeutics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siga Technologies$94.57M2.28$23.28M-$0.05N/A
Gyre Therapeutics$116.59M6.39$5.03M-$0.21N/A

Siga Technologies has a beta of 0.97, meaning that its share price is 3% less volatile than the broader market. Comparatively, Gyre Therapeutics has a beta of 1.92, meaning that its share price is 92% more volatile than the broader market.

55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 24.0% of Gyre Therapeutics shares are held by institutional investors. 2.7% of Siga Technologies shares are held by insiders. Comparatively, 9.5% of Gyre Therapeutics shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

In the previous week, Gyre Therapeutics had 2 more articles in the media than Siga Technologies. MarketBeat recorded 3 mentions for Gyre Therapeutics and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.63 beat Gyre Therapeutics' score of -0.09 indicating that Siga Technologies is being referred to more favorably in the media.

Company Overall Sentiment
Siga Technologies Positive
Gyre Therapeutics Neutral

Siga Technologies has a net margin of -5.19% compared to Gyre Therapeutics' net margin of -15.47%. Siga Technologies' return on equity of -1.55% beat Gyre Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Siga Technologies-5.19% -1.55% -1.32%
Gyre Therapeutics -15.47%-6.57%-5.35%

Gyre Therapeutics has a consensus target price of $17.00, indicating a potential upside of 154.49%. Given Gyre Therapeutics' stronger consensus rating and higher probable upside, analysts clearly believe Gyre Therapeutics is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Gyre Therapeutics
1 Sell rating(s)
1 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.25

Summary

Gyre Therapeutics beats Siga Technologies on 9 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Oculis?

Siga Technologies (NASDAQ:SIGA) and Oculis (NASDAQ:OCS) are both small-cap healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, media sentiment, earnings, analyst recommendations, dividends, institutional ownership, valuation and risk.

55.4% of Siga Technologies shares are held by institutional investors. Comparatively, 22.3% of Oculis shares are held by institutional investors. 2.7% of Siga Technologies shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Siga Technologies has a net margin of -5.19% compared to Oculis' net margin of -6,777.18%. Siga Technologies' return on equity of -1.55% beat Oculis' return on equity.

Company Net Margins Return on Equity Return on Assets
Siga Technologies-5.19% -1.55% -1.32%
Oculis -6,777.18%-42.61%-35.23%

Siga Technologies has higher revenue and earnings than Oculis. Siga Technologies is trading at a lower price-to-earnings ratio than Oculis, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Siga Technologies$94.57M2.28$23.28M-$0.05N/A
Oculis$1.45M517.42-$119.44M-$1.74N/A

Siga Technologies has a beta of 0.97, meaning that its stock price is 3% less volatile than the broader market. Comparatively, Oculis has a beta of 0.51, meaning that its stock price is 49% less volatile than the broader market.

In the previous week, Oculis had 22 more articles in the media than Siga Technologies. MarketBeat recorded 23 mentions for Oculis and 1 mentions for Siga Technologies. Oculis' average media sentiment score of 0.65 beat Siga Technologies' score of 0.63 indicating that Oculis is being referred to more favorably in the news media.

Company Overall Sentiment
Siga Technologies Positive
Oculis Positive

Oculis has a consensus price target of $38.00, suggesting a potential upside of 193.66%. Given Oculis' stronger consensus rating and higher probable upside, analysts plainly believe Oculis is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00
Oculis
1 Sell rating(s)
0 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.80

Summary

Siga Technologies beats Oculis on 9 of the 16 factors compared between the two stocks.

How does Siga Technologies compare to Achieve Life Sciences?

Achieve Life Sciences (NASDAQ:ACHV) and Siga Technologies (NASDAQ:SIGA) are both small-cap healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their analyst recommendations, institutional ownership, profitability, valuation, dividends, earnings, risk and media sentiment.

Achieve Life Sciences has a net margin of 0.00% compared to Siga Technologies' net margin of -5.19%. Siga Technologies' return on equity of -1.55% beat Achieve Life Sciences' return on equity.

Company Net Margins Return on Equity Return on Assets
Achieve Life SciencesN/A -511.12% -82.35%
Siga Technologies -5.19%-1.55%-1.32%

Siga Technologies has higher revenue and earnings than Achieve Life Sciences. Siga Technologies is trading at a lower price-to-earnings ratio than Achieve Life Sciences, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Achieve Life SciencesN/AN/A-$54.65M-$1.55N/A
Siga Technologies$94.57M2.28$23.28M-$0.05N/A

33.5% of Achieve Life Sciences shares are owned by institutional investors. Comparatively, 55.4% of Siga Technologies shares are owned by institutional investors. 1.8% of Achieve Life Sciences shares are owned by insiders. Comparatively, 2.7% of Siga Technologies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Achieve Life Sciences has a beta of 2.24, suggesting that its stock price is 124% more volatile than the broader market. Comparatively, Siga Technologies has a beta of 0.97, suggesting that its stock price is 3% less volatile than the broader market.

Achieve Life Sciences currently has a consensus price target of $15.00, suggesting a potential upside of 97.63%. Given Achieve Life Sciences' stronger consensus rating and higher probable upside, research analysts plainly believe Achieve Life Sciences is more favorable than Siga Technologies.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Achieve Life Sciences
1 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
2 Strong Buy rating(s)
3.00
Siga Technologies
1 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.00

In the previous week, Achieve Life Sciences had 19 more articles in the media than Siga Technologies. MarketBeat recorded 20 mentions for Achieve Life Sciences and 1 mentions for Siga Technologies. Siga Technologies' average media sentiment score of 0.63 beat Achieve Life Sciences' score of 0.16 indicating that Siga Technologies is being referred to more favorably in the news media.

Company Overall Sentiment
Achieve Life Sciences Neutral
Siga Technologies Positive

Summary

Achieve Life Sciences and Siga Technologies tied by winning 8 of the 16 factors compared between the two stocks.

Get Siga Technologies News Delivered to You Automatically

Sign up to receive the latest news and ratings for SIGA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SIGA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SIGA vs. The Competition

Export
MetricSiga TechnologiesPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market Cap$206.93M$11.89B$7.06B$13.10B
Dividend YieldN/A2.70%2.57%10.45%
P/E Ratio-60.00640.15211.0921.74
Price / Sales2.28743.87602.9892.99
Price / Cash8.6566.4570.4850.90
Price / Book1.3011.6012.916.24
Net Income$23.28M$2.77B$3.45B$347.60M
7 Day Performance-1.64%0.17%1.12%1.07%
1 Month Performance-12.28%0.35%1.79%1.03%
1 Year Performance-65.03%161.52%67.69%20.77%

Siga Technologies Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SIGA
Siga Technologies
0.5478 of 5 stars		$3.00
+4.2%		N/A-67.2%$206.93M$94.57MN/A40
ESPR
Esperion Therapeutics
1.9698 of 5 stars		$3.18
flat		$5.54
+74.2%		N/A$819.45M$403.14MN/A200
GLAS
Glass House Brands
3.5693 of 5 stars		$9.92
-0.9%		$17.00
+71.4%		N/A$796.04MN/AN/AN/A
GYRE
Gyre Therapeutics
2.3623 of 5 stars		$6.64
-1.2%		$17.00
+156.0%		-20.3%$738.62M$109.82MN/A40
OCS
Oculis
2.9901 of 5 stars		$12.73
-0.3%		$38.33
+201.2%		-28.8%$737.80M$1.45MN/A2

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SIGA) was last updated on 8/14/2026 by MarketBeat.com Staff.
From Our Partners
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
Wall Street is staring at the wrong AI trade
Anthropic just signed a 9.1 billion dollar, 20 year data center agreement covering 191 megawatts of capacity, ...
The Oxford Club | Sponsoredtc pixel
Ray Dalio: Buy Gold. Get Paid.
Ray Dalio, founder of Bridgewater Associates, is urging investors to hold 15% of their portfolio in gold and c...
Investors Alley | Sponsoredtc pixel
Your book is inside
The "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...
Profits Run | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel
Who Really Gets Rich from IPOs?
Peter Thiel turned a $500,000 stake in Meta into nearly $1 billion by investing eight years before its IPO. Tr...
Weiss Ratings | Sponsoredtc pixel
$100 for this… $500 for that. Here’s how to stop the bleeding today
Rising costs are squeezing households nationwide. USA Today reports more families are moving in together, whil...
Brownstone Research | Sponsoredtc pixel